Cargando…
DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
Autores principales: | Cui, Qiuxia, Sun, Jian, Yuan, Jingping, Li, Juanjuan, Yang, Chuanyu, Du, Guangshi, Zhou, Chengang, Qiu, Pu, Gao, Jidong, Zhang, Yuanqi, Jiang, Dewei, Chen, Ceshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425834/ https://www.ncbi.nlm.nih.gov/pubmed/37588224 http://dx.doi.org/10.1016/j.gendis.2023.03.028 |
Ejemplares similares
-
Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
por: Zhao, Ping, et al.
Publicado: (2023) -
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022) -
The tumor-nerve circuit in breast cancer
por: Cui, Qiuxia, et al.
Publicado: (2023) -
Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016) -
Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
por: Chen, Chuan-Huizi, et al.
Publicado: (2019)